Delivery Order SPE2DB22D2005-SPE2DB25FJRZ9
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate 5 mg chewable tablets (100-count units) valued at $3,794.71 with a firm fixed price structure. This non-set-aside, competitively awarded contract is scheduled for completion by August 1, 2025, and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The vendor will perform fulfillment from its Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units, with a contract ceiling value of $1,231.28. This firm fixed-price delivery order, which is scheduled for completion by August 19, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 2.5 mg chewable tablets (100-count units) with a contract value of $1,620.98. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, under a firm fixed-price delivery order structure. The contract was competitively awarded with no set-aside designation, and performance is based at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,076.21 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 10 mg chewable tablets in quantities of 100 units. This contract award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,149.78 to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate 5 mg chewable formulation, with an ultimate completion date of July 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,852.00 for 100 tablets of Methylphenidate 2.5 mg chewable formulation. This non-set-aside contract was competitively awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) valued at $2,634.43. This is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100 count) valued at $4,175.73 on August 11, 2025, with completion targeted for August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The products will be performed from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,387.40 to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100 count) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. Methylphenidate is a central nervous system stimulant commonly used in military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $3,150.33. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the federal pharmaceutical procurement process. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRZ9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100 count) under a firm fixed price contract valued at $3,736.67. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract demonstrates AmerisourceBergen Drug Corp's ongoing role as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems managed by the Defense Health Agency and related government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/19/25 |